Search clinical trials for: Aluminum Hydroxide Adjuvant

Total 8506 results

Shanghai Institute Of Biological Products

Unknown

A Study of An Adjuvanted Inactivated H7N9 Influenza Vaccine

H7N9 Influenza

China
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Immunogenicity of an HIV Vaccine (gp145 C.6980) in Healthy, HIV-Uninfected Adults in the United States

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Dose, Safety, Tolerability, and Immunogenicity of an HIV-1 Vaccine, VRC-HIVRGP096-00-VP, With Alum in Healthy Adults

Human Immunodeficiency Virus (HIV) | Human Immunodeficiency Virus Prevention

United States
National Institute of Diabetes and Digestive and...
National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy... and other collaborators

Completed

Effects of Recombinant Human Glutamic Acid Decarboxylase on the Progression of Type 1 Diabetes in New Onset Subjects (TN08)

Type 1 Diabetes Mellitus

United States, Canada
U.S. Army Medical Research and Development Command
Walter Reed Army Institute of Research (WRAIR)

Completed

Safety Study of a Capsule-Conjugate Vaccine to Prevent Campylobacter-Caused Diarrhea (CJCV1-01)

Campylobacter Infection

United States
National Institute of Allergy and Infectious Diseases...

Withdrawn

Phase I Dose Escalation SARS-CoV Recombinant S Protein, With and Without Adjuvant, Vaccine Study

SARS

United States
Radboud University Medical Center
Institut Pasteur

Completed

Safety and Efficacy Study of Plasmodium Falciparum LSA-3 Malaria Vaccine (LSA-3-rec)

Healthy

Netherlands
MEDA Pharma GmbH & Co. KG
ICON plc; Clinipace Worldwide; Trium Analysis Online GmbH

Terminated

Tepilta® Versus Oxetacaine, Antacids and Placebo

Radiation-induced Oesophagitis

Germany, Austria
National Institute of Allergy and Infectious Diseases...

Completed

The Effectiveness of Human Antibodies in Influencing an AIDS-Like Disease in Monkeys

HIV Infections
Spero Therapeutics

Completed

Study to Examine the Effect of Antacid and Omeprazole on the Single-Dose Pharmacokinetics of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) in Healthy Adult Subjects

Healthy Volunteers

United States
GlaxoSmithKline

Completed

A Study to Evaluate the Safety and Ability of the Vaccine to Induce Antibodies Against the Respiratory Syncytial Virus in Healthy Adults

Respiratory Syncytial Virus (RSV)

Belgium
National Institute of Allergy and Infectious Diseases...

Completed

Phase I STEBVax in Healthy Adults

Toxic Shock Syndrome Staphylococcal

United States
MedImmune LLC
GlaxoSmithKline

Completed

Study to Evaluate the Safety and Immunogenicity of MEDI-517P in Healthy Adult Female Volunteers Who Are HPV-16 or HPV-18 DNA Positive

Healthy
Baylor College of Medicine
National Institute on Drug Abuse (NIDA); Johns Hopkins University; University... and other collaborators

Completed

Multisite Controlled Trial of Cocaine Vaccine (TA-CD)

Cocaine Dependence

United States
Shanghai Institute Of Biological Products
Henan Center for Disease Control and Prevention

Unknown

A Clinical Trail Of An Adjuvanted Inactivated H7N9 Influenza Vaccine

H7N9 Influenza

China
GlaxoSmithKline

Recruiting

A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years

Hepatitis B

Germany, United Kingdom, Belgium
Genocea Biosciences, Inc.

Completed

Safety, Tolerability, and Efficacy Study of Prophylactic S. Pneumoniae Vaccine Following Challenge With S. Pneumoniae

Pneumococcal Infections | Pneumonia, Pneumococcal

United Kingdom
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults.

HIV Infections

United States
H. Lundbeck A/S

Completed

A Study to Evaluate a New Tablet Formulation of Lu AG06466 in Healthy Participants

Healthy

United Kingdom
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of MN Recombinant Soluble gp120/HIV-1 (rsgp120/HIV-1) (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I Safety and Immunogenicity Study of HIV p17/p24:Ty-VLP in HIV-1 Seronegative Subjects

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Active, not recruiting

Evaluating the Safety and Immunogenicity of Stabilized CH505 TF chTrimer in Healthy, HIV-uninfected Adult Participants.

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Dose, Safety, Tolerability and Immunogenicity of a Stabilized Prefusion RSV F Subunit Protein Vaccine, VRC-RSVRGP084-00-VP (DS-Cav1), Alone or With Alum Adjuvant, in Healthy Adults

Respiratory Syncytial Virus

United States
Clover Biopharmaceuticals AUS Pty Ltd

Completed

Safety and Immunogenicity Dose-finding Study of Adjuvanted SCB-2020S Vaccine in Adults

COVID-19

South Africa
National Institute of Allergy and Infectious Diseases...

Withdrawn

Safety and Effectiveness of Two Different Formulations of an HIV Vaccine in Infants Born to HIV-Infected Women

HIV Infections | HIV Seronegativity
National Institute of Allergy and Infectious Diseases...

Completed

H5 Vaccine Alone or With Aluminum Hydroxide in Elderly Adults

Influenza

United States
Jiangsu Province Centers for Disease Control and...
Bejing Vigoo Biological Co., LTD

Completed

A Booster Dose of Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children

EV71-associated Disease

China
National Institute of Allergy and Infectious Diseases...

Withdrawn

SARS Coronavirus Vaccine (SARS-CoV)

Coronavirus (SARS-CoV)

United States
National Institute of Allergy and Infectious Diseases...

Completed

Dose-Escalating Trial Using Vero Cell-culture Derived H5N1 +/- Aluminum in Adults

Influenza

United States
Clover Biopharmaceuticals AUS Pty Ltd

Completed

SCB-2019 as COVID-19 Vaccine

COVID-19

Australia
National Institute of Allergy and Infectious Diseases...

Completed

H5 Adult - Chiron Study of Bird Flu Vaccine

Influenza

United States
University of Oxford

Recruiting

KLH Challenge to Explore the Human Immune Response

Immune Response

United Kingdom
Leti Pharma GmbH

Completed

Dose Finding Study Depigoid Phleum: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma

Allergic Rhinitis/Rhinoconjunctivitis +- Intermittent Asthma | Sensitization Against Phleum Pratense Pollen | Dose-Finding Study

Germany
National Institute of Allergy and Infectious Diseases...

Completed

H5 Vaccine Alone or With Adjuvant in Healthy Adults

Influenza

United States
Tehran University of Medical Sciences

Completed

Two Schedules of Hepatitis B Vaccination in Predialysis Chronic Renal Failure Patients

Renal Failure
National Institute of Allergy and Infectious Diseases...

Completed

VRC 313: A Trivalent Virus-like Particle (VLP) Encephalitis Vaccine (WEVEE) in Healthy Adults

Alphavirus Infections | Eastern Equine Encephalitis | Venezuelan Equine Encephalitis | Western Equine Encephalitis

United States
Medigen Vaccine Biologics Corp.

Completed

A Clinical Study for Inactivated Vaccine Against EV71 (EV71)

Enterovirus 71 Human

Taiwan
Laboratorios Leti, S.L.

Completed

Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Parietaria Judaica

Allergic Rhinoconjunctivitis

Spain
University of Alabama at Birmingham
National Cancer Institute (NCI)

Completed

Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Melanoma

Melanoma (Skin)
U.S. Army Medical Research and Development Command
GlaxoSmithKline; Walter Reed Army Institute of Research (WRAIR)

Completed

A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (DPIV-001)

Dengue Fever

United States
Vaxine Pty Ltd
Flinders Medical Centre

Completed

Safety and Efficacy Study of Adjuvanted Prophylactic Hepatitis B Vaccine

Exposure to Hepatitis B Virus

Australia
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I Comparative Blinded Trial of Several HIV-1 Derived Immunogens in Infected Individuals With >= 500 CD4 Cells/mm3

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Study to Evaluate the Safety and Effectiveness of HIV-1 LAI gp120 (an HIV Vaccine) Given With or Without HIV-1 MN rgp120 (Another HIV Vaccine) to HIV-Negative Volunteers

HIV Infections | HIV Seronegativity

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Compare the Safety and Immunogenicity of Recombinant Envelope Protein rgp120/HIV-1SF2 (BIOCINE) Combined With Seven Adjuvants in Healthy HIV-1 Uninfected Individuals

HIV Infections

United States
U.S. Army Medical Research and Development Command
GlaxoSmithKline; Walter Reed Army Institute of Research (WRAIR)

Completed

A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (in Puerto Rico) (DPIV-002)

Dengue Fever

Puerto Rico
U.S. Army Medical Research and Development Command

Completed

TDENV PIV and LAV Dengue Prime-boost Strategy

Dengue

United States
National Institute of Allergy and Infectious Diseases...

Completed

Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants

Pertussis | Tetanus | Diphtheria | Diphtheria Immunisation | Tetanus Immunisation | Clostridium Difficile Immunisation

Mali
VaxGen

Completed

A Study of AIDSVAX B/B and AIDSVAX B/E, Two Possible Vaccines

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
PepTcell Limited (t/a SEEK)

Completed

Evaluating the Safety and Immunogenicity of AGS-v PLUS, a Universal Mosquito-Borne Disease and Mosquito Control Vaccine

Mosquito-Borne Infectious Diseases

United States
University of Southern California
National Cancer Institute (NCI)

Completed

Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma

Intraocular Melanoma | Melanoma (Skin)

United States

Search clinical trials for: Aluminum Hydroxide Adjuvant

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations